Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹2,186 Cr₹-1,560 Cr₹1,587 Cr₹-177 Cr₹319 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of GLAND PHARMA is ₹2,186 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹2,186 Cr
Mar2024₹-1,560 Cr
Mar2023₹1,587 Cr
Mar2022₹-177 Cr
Mar2021₹319 Cr

How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹2,186 Cr
Positive
Mar2024 ₹-1,560 Cr
Negative
Mar2023 ₹1,587 Cr
Positive
Mar2022 ₹-177 Cr
Negative
Mar2021 ₹319 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹40,598.3 Cr 3.7% 10.2% 36.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.7%

10.2%

36.4%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses